Wilmer Cutler Pickering Hale and Dorr advised Ratio Therapeutics Inc in the transaction. Ratio Therapeutics Inc, a pharmaceutical company, announced its exclusive worldwide license and collaboration...
Ratio Therapeutics’ License and Collaboration Agreement with Novartis
Eliem Therapeutics’ Acquisition of Tenet Medicines and Concurrent $120 Million Private Placement
Wilmer Cutler Pickering Hale and Dorr advised Eliem Therapeutics on the deal, and Cooley advised Tenet Medicines. Eliem Therapeutics, Inc. (Nasdaq: ELYM), announced that it had entered into...